The kidney and hypertension: Novel insights from transgenic models

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 2, 2012, Pages 171-178

  Herrera, Marcela ^a   Coffman, Thomas M ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

angiotensin II; hypertension; kidney; knockout; transgenic

Indexed keywords

APOCYNIN; DOPAMINE; ENDOTHELIN; MINERALOCORTICOID RECEPTOR; NITRIC OXIDE; PROTEIN SERINE THREONINE KINASE; TEMPOL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CELL LINEAGE; ESSENTIAL HYPERTENSION; GENOME; HOMEOSTASIS; HYPERKALEMIA; KIDNEY TUBULE EXCRETION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SODIUM BALANCE; SODIUM EXCRETION; SODIUM RETENTION; TRANSGENIC ANIMAL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PRESSURE; DOPAMINE; ENDOTHELIN-1; HYPERTENSION; KIDNEY TUBULES, PROXIMAL; MICE; NATRIURESIS; NITRIC OXIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SODIUM;

EID: 84856815284     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283503068     Document Type: Review

References (42)

1. Guyton AC. The surprising kidney-fluid mechanism for pressure control: Its infinite gain! Hypertension 1990; 16:725-730.
2. Graf C, Maser-Gluth C, de Muinck Keizer W, et al. Sodium retention and hypertension after kidney transplantation in rats. Hypertension 1993; 21:724-730. (Pubitemid 23120229)
3. Kopf D, Waldherr R, Rettig R. Source of kidney determines blood pressure in young renal transplanted rats. Am J Physiol 1993; 265 (1 Pt 2):F104-111. (Pubitemid 23221557)
4. Rettig R, Folberth CG, Graf C, et al. Posttransplantation hypertension in recipients of renal grafts from hypertensive donor rats. Clin Invest Med 1991; 14:492-498.
5. Rettig R, Folberth CG, Stauss H, et al. Hypertension in rats induced by renal grafts from renovascular hypertensive donors. Hypertension 1990; 15:429-435. (Pubitemid 20137600)
6. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556. (Pubitemid 32201949)
7. Lubkemeier I, Machura K, Kurtz L, et al. The connexin 40 A96S mutation causes renin-dependent hypertension. J Am Soc Nephrol 2011; 22:1031-1040.
8. Beierwaltes WH. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3. Am J Physiol Renal Physiol 2006; 290:F1376-1381. (Pubitemid 43830762)
9. Beierwaltes WH. The role of calcium in the regulation of renin secretion. Am J Physiol Renal Physiol 2010; 298:F1-F11.
10. Ortiz-Capisano MC, Ortiz PA, Harding P, et al. Adenylyl cyclase isoform v mediates renin release from juxtaglomerular cells. Hypertension 2007; 49:618-624.
11. Sayago CM, Beierwaltes WH. Nitric oxide synthase and cGMP-mediated stimulation of renin secretion. Am J Physiol Regul Integr Comp Physiol 2001; 281:R1146-1151.
12. Sequeira Lopez ML, Gomez RA. Novel mechanisms for the control of renin synthesis and release. Curr Hypertens Rep 2010; 12:26-32.
13. Facemire CS, Nguyen M, Jania L, et al. A major role for the EP4 receptor in regulation of renin. Am J Physiol Renal Physiol 2011; 301:F1035-F1041.
14. Kobori H, Nangaku M, Navar LG, et al. The intrarenal renin-Angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59:251-287. (Pubitemid 47481436)
15. Navar LG, Harrison-Bernard LM, Nishiyama A, et al. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39 (2 Pt 2):316-322. (Pubitemid 34165142)
16. Navar LG, Prieto MC, Satou R, et al. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011; 11:180-186.
17. Gonzalez-Villalobos RA, Billet S, Kim C, et al. Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J Am Soc Nephrol 2011; 22:449-459.
18. Garvin JL. Angiotensin stimulates glucose and fluid absorption by rat proximal straight tubules. J Am Soc Nephrol 1990; 1:272-277.
19. Garvin JL. Angiotensin stimulates bicarbonate transport and Na+/K+ ATPase in rat proximal straight tubules. J Am Soc Nephrol 1991; 1:1146-1152.
20. Hall JE. Control of sodium excretion by angiotensin II: Intrarenal mechanisms and blood pressure regulation. Am J Physiol 1986; 250:R960-972.
21. Harris PJ, Young JA. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch 1977; 367:295-297. (Pubitemid 8014493)
22. Crowley SD, Gurley SB, Herrera MJ, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006; 103:17985-17990. (Pubitemid 44852272)
23. Crowley SD, Zhang J, Herrera M, et al. The role of AT1 receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol 2011; 301:F1124-F1130.
24. Gurley SB, Riquier-Brison AD, Schnermann J, et al. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 2011; 13:469-475. This article highlights the importance of AT1 receptors in the proximal tubule of the kidney in blood pressure homeostasis.
25. Li H, Weatherford ET, Davis DR, et al. Renal proximal tubule angiotensin AT1A receptors regulate blood pressure. Am J Physiol Regul Integr Comp Physiol 2011; 301:R1067-R1077. This article highlights the importance of AT1 receptors in the proximal tubule of the kidney in blood pressure homeostasis.
26. Shibata S, Nagase M, Yoshida S, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease. Nat Med 2008; 14:1370-1376.
27. Shibata S, Mu S, Kawarazaki H, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptordependent pathway. J Clin Invest 2011; 121:3233-3243. This article demonstrated that over-Activation of Rac1 causes hypertension by augmenting activity of the mineralocorticoid receptor.
28. Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112. (Pubitemid 32758085)
29. McCormick JA, Mutig K, Nelson JH, et al. A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab 2011; 14:352-364. This article shows that SPAK kinases diferentially regulate sodium transport in the distal nephron impacting blood pressure.
30. Herrera M, Garvin JL. A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1. Am J Physiol Renal Physiol 2005; 288:F58-64. (Pubitemid 40038676)
31. Ahn D, Ge Y, Stricklett PK, et al. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 2004; 114:504-511. (Pubitemid 39572100)
32. Ge Y, Bagnall A, Stricklett PK, et al. Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol 2006; 291:F1274-1280. (Pubitemid 44889187)
33. Ge Y, Bagnall A, Stricklett PK, et al. Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. Am J Physiol Renal Physiol 2008; 295:F1635-1640.
34. Bugaj V, Mironova E, Kohan DE, et al. Collecting duct-specific endothelin B receptor knockout increases ENaC activity. Am J Physiol Cell Physiol 2011; 302:C188-C194. These studies showed that ETB receptor activation inhibits ENaC open probability in the collecting duct, promoting natriuresis during high salt intake.
35. Zhang Y, Jose PA, Zeng C. Regulation of sodium transport in the proximal tubule by endothelin. Contrib Nephrol 2011; 172:63-75.
36. Herrera M, Hong NJ, Ortiz PA, et al. Endothelin-1 inhibits thick ascending limb transport via Akt-stimulated nitric oxide production. J Biol Chem 2009; 284:1454-1460.
37. Ramseyer VD, Cabral PD, Garvin JL. Role of endothelin in thick ascending limb sodium chloride transport. Contrib Nephrol 2011; 172:76-83.
38. Kopkan L, Hess A, Huskova Z, et al. High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity. Am J Physiol Renal Physiol 2010; 299:F656-663. This article highlights the importance of nitric oxide derived from eNOS in preventing salt-sensitive hypertension via its actions within the kidney.
39. Perez-Rojas JM, Kassem KM, Beierwaltes WH, et al. Nitric oxide produced by endothelial nitric oxide synthase promotes diuresis. Am J Physiol Regul Integr Comp Physiol 2010; 298:R1050-1055. This study demonstrated the importance of nitric oxide derived from eNOS to promote natriuresis by inhibiting NKCC2 in the thick ascending limb.
40. Sanada H, Yatabe J, Midorikawa S, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006; 52:352-360.
41. Zhang MZ, Yao B, Wang S, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011; 121: 2845-2854. This article highlights the importance of dopamine synthesized in the renal proximal tubule as an antinatriuretic factor controling blood pressure homeostasis.
42. Li H, Armando I, Yu P, et al. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 2008; 118:2180-2189. (Pubitemid 351872336)